<DOC>
	<DOCNO>NCT01604733</DOCNO>
	<brief_summary>Study objective evaluate level control hypercholesterolemia Egypt patient take lipid lower agent least 3 month ( drug change dose amendment minimum 6 week ) .</brief_summary>
	<brief_title>Centralized Pan-Middle East Survey Undertreatment Hypercholesterolemia</brief_title>
	<detailed_description>Centralized Pan-Middle East Survey Undertreatment Hypercholesterolemia</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>18 year current lipid lower drug least 3 month dose change minimum 6 week Subject must provide informed consent comply survey procedures Less 18 year less 3 month antidyslipidemic agent Subjects unwilling unable provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Multi-Center Survey</keyword>
	<keyword>patient currently lipid-lowering pharmacological treatment</keyword>
	<keyword>level Control Hypercholesterolemia Egypt</keyword>
</DOC>